OPKO Health’s (OPK) Board of Directors has authorized an increase of $100M to the Company’s existing common stock repurchase program, bringing the aggregate capacity of the program to $200M. Approximately $41M of OPKO’s common stock has been repurchased under the existing program since its authorization in July 2024.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPK:
- Opko Health management to meet with Piper Sandler
- Best Buy, Las Vegas Sands, Globalstar, Opko Health, Agilent: Stock Moves Unveiled
- Strategic Partnerships and Asset Sales Bolster OPKO Health’s Growth Prospects
- Opko Health CEO buys $348K in common stock
- Opko Health, Entera Bio enter collaboration agreement for GLP-1/glucagon peptide